sellNotable cluster of 6
BENKOWITZ MICHAEL sold $5.5M of UTHR
PRESIDENT AND COO at UNITED THERAPEUTICS Corp. 14,700 shares at an average of $374.46, traded Nov 1, 2024, filed Nov 4, 2024.
Warning score
65Value
$5.5M
14,700 shares
Holdings after
0
-100% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001415889-24-025975, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 1, 2024 | MOption exercise Common Stockindirect: By Trust | +14,700 | $120.26 | $1.8M | 14,700 | Nov 4, 2024 |
| Nov 1, 2024 | SOpen-market sale Common Stockindirect: By Trust | -200 | $370.65 | $74k | 14,500 | Nov 4, 2024 |
| Nov 1, 2024 | SOpen-market sale Common Stockindirect: By Trust | -800 | $371.71 | $297k | 13,700 | Nov 4, 2024 |
| Nov 1, 2024 | SOpen-market sale Common Stockindirect: By Trust | -1,200 | $373.05 | $448k | 12,500 | Nov 4, 2024 |
| Nov 1, 2024 | SOpen-market sale Common Stockindirect: By Trust | -6,096 | $374.02 | $2.3M | 6,404 | Nov 4, 2024 |
| Nov 1, 2024 | SOpen-market sale Common Stockindirect: By Trust | -3,501 | $375.06 | $1.3M | 2,903 | Nov 4, 2024 |
| Nov 1, 2024 | SOpen-market sale Common Stockindirect: By Trust | -1,803 | $375.83 | $678k | 1,100 | Nov 4, 2024 |
| Nov 1, 2024 | SOpen-market sale Common Stockindirect: By Trust | -1,000 | $376.94 | $377k | 100 | Nov 4, 2024 |
| Nov 1, 2024 | SOpen-market sale Common Stockindirect: By Trust | -100 | $378.00 | $38k | 0 | Nov 4, 2024 |
| Nov 1, 2024 | MOption exercise Stock Optionsderivativeindirect: By Trust | -14,700 | $0.00 | $0 | 4,500 | Nov 4, 2024 |
Related signals
Other insiders at UNITED THERAPEUTICS Corp and this insider’s other filings.
| Score | Side | Company | Insider | Value | Shares | Filed |
|---|---|---|---|---|---|---|
| 38Weak | sell 210b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $3.6M | 10,000 | |
| 32Weak | sell 2 | UTHR UNITED THERAPEUTICS Corp | Mesa Nilda director | $91k | 255 | |
| 38Weak | sell 210b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $3.6M | 10,000 | |
| 45Moderate | sell 310b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $3.7M | 10,000 | |
| 38Weak | sell 210b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $3.7M | 10,000 | |
| 18Weak | sell 210b5-1 | UTHR UNITED THERAPEUTICS Corp | MAHON PAUL A EVP & GENERAL COUNSEL | $2.9M | 7,700 | |
| 38Weak | sell 210b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $3.7M | 10,000 | |
| 45Moderate | sell 310b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $3.7M | 10,000 | |
| 25Weak | sell 410b5-1 | UTHR UNITED THERAPEUTICS Corp | MAHON PAUL A EVP & GENERAL COUNSEL | $2.8M | 7,700 | |
| 45Moderate | sell 610b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $3.6M | 10,000 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.